Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parham Habibzadeh

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Cancer|February 10, 2026
Revisiting the impact of common medications on immune checkpoint inhibitor efficacyParham Habibzadeh, Diwakar Davar
Journal of Clinical Medicine|November 9, 2024
Association Between Race and Comorbid Conditions Among Older Adults with DementiaParham Habibzadeh, Jennifer Albrecht
Croatian Medical Journal|November 4, 2015
How much precision in reporting statistics is enough?Farrokh Habibzadeh, Parham Habibzadeh
Journal of Korean Medical Science|November 19, 2024
Risk Adjustment in Medical Research: A Bird's Eye ViewParham Habibzadeh, Farrokh Habibzadeh
The International Journal of Occupational and Environmental Medicine|February 6, 2020
The Novel Coronavirus: A Bird's Eye ViewParham Habibzadeh, Emily K Stoneman
Biochemia Medica|July 8, 2022
The apparent prevalence, the true prevalenceFarrokh Habibzadeh, Parham Habibzadeh, Mahboobeh Yadollahie
Biochemia Medica|November 5, 2016
On determining the most appropriate test cut-off value: the case of tests with continuous resultsFarrokh Habibzadeh, Parham Habibzadeh, Mahboobeh Yadollahie
Diabetes Research and Clinical Practice|February 14, 2017
Criterion used for determination of test cut-off valueFarrokh Habibzadeh, Parham Habibzadeh, Mahboobeh Yadollahie
European Urology|June 1, 2017
What is a "Diagnostic Test Reference Range" Good for?Parham Habibzadeh, Mahboobeh Yadollahie, Farrokh Habibzadeh
Acta Medica Academica|November 1, 2022
On Measuring Vaccine Effectiveness with Observational Study DesignsFarrokh Habibzadeh, Parham Habibzadeh, Mahboobeh Yadollahie
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Cancer|February 10, 2026
Revisiting the impact of common medications on immune checkpoint inhibitor efficacyParham Habibzadeh, Diwakar Davar
Journal of Clinical Medicine|November 9, 2024
Association Between Race and Comorbid Conditions Among Older Adults with DementiaParham Habibzadeh, Jennifer Albrecht
Croatian Medical Journal|November 4, 2015
How much precision in reporting statistics is enough?Farrokh Habibzadeh, Parham Habibzadeh
Journal of Korean Medical Science|November 19, 2024
Risk Adjustment in Medical Research: A Bird's Eye ViewParham Habibzadeh, Farrokh Habibzadeh
The International Journal of Occupational and Environmental Medicine|February 6, 2020
The Novel Coronavirus: A Bird's Eye ViewParham Habibzadeh, Emily K Stoneman
Biochemia Medica|July 8, 2022
The apparent prevalence, the true prevalenceFarrokh Habibzadeh, Parham Habibzadeh, Mahboobeh Yadollahie
Biochemia Medica|November 5, 2016
On determining the most appropriate test cut-off value: the case of tests with continuous resultsFarrokh Habibzadeh, Parham Habibzadeh, Mahboobeh Yadollahie
Diabetes Research and Clinical Practice|February 14, 2017
Criterion used for determination of test cut-off valueFarrokh Habibzadeh, Parham Habibzadeh, Mahboobeh Yadollahie
European Urology|June 1, 2017
What is a "Diagnostic Test Reference Range" Good for?Parham Habibzadeh, Mahboobeh Yadollahie, Farrokh Habibzadeh
Acta Medica Academica|November 1, 2022
On Measuring Vaccine Effectiveness with Observational Study DesignsFarrokh Habibzadeh, Parham Habibzadeh, Mahboobeh Yadollahie
Pageof 6